Hospitalizations, outcomes, and management costs of febrile neutropenia in patients from a managed care population-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hospitalizations, outcomes, and management costs of febrile neutropenia in patients from a managed care population

Published:2017-04-10 Issue:9 Volume:25 Page:2787-2795
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Kawatkar Aniket A.,Farias Albert J.,Chao Chun,Chen Wansu,Barron Richard,Vogl Florian D.,Chandler David B.

Funder

Amgen

National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/article/10.1007/s00520-017-3692-x/fulltext.html

Reference26 articles.

1. Caggiano V, Weiss RV, Rickert TS, Linde-Zwirble WT (2005) Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy. Cancer 103(9):1916–1924. doi: 10.1002/cncr.20983

2. Weycker D, Barron R, Kartashov A, Legg J, Lyman GH (2014) Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings. J Oncol Pharm Pract 20(3):190–198. doi: 10.1177/1078155213492450

3. Weycker D, Edelsberg J, Kartashov A, Barron R, Lyman G (2012) Risk and healthcare costs of chemotherapy-induced neutropenic complications in women with metastatic breast cancer. Chemotherapy 58(1):8–18. doi: 10.1159/000335604

4. Hirsch BR, Lyman GH (2012) Pharmacoeconomics of the myeloid growth factors: a critical and systematic review. PharmacoEconomics 30(6):497–511. doi: 10.2165/11590130-000000000-00000

5. Wildiers H, Reiser M (2011) Relative dose intensity of chemotherapy and its impact on outcomes in patients with early breast cancer or aggressive lymphoma. Crit Rev Oncol Hematol 77(3):221–240. doi: 10.1016/j.critrevonc.2010.02.002

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Knowledge, Attitude, and Practice in Preventing Infection Among Patients With Cancer Receiving Chemotherapy;Journal of Nursing Care Quality;2024-04-03

2. A prospective, real-world, multinational study of febrile neutropenia (FN) occurrence in oncology patients receiving chemotherapy with intermediate risk of FN: a MASCC Neutropenia, Infection, and Myelosuppression Study Group initiative;Supportive Care in Cancer;2023-10-13

3. Real-World Impact of Prophylactic Growth Factor Use on Timing of Febrile Neutropenia and Infection After High-Risk Chemotherapy;Journal of the National Comprehensive Cancer Network;2023-09

4. Prescription patterns of granulocyte colony–stimulating factors in patients with breast cancer: A real-world study;PLOS ONE;2023-07-17

5. Effectiveness and Safety of Filgrastim (Neupogen™) versus Filgrastim-aafi (Nivestim™) in Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia: An Observational Cohort Study;Drugs - Real World Outcomes;2022-09-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3